Additional therapeutic effects may be achieved via CsA and tacrolimus» anti-inflammatory effects, stimulatory effect on lacrimal glands, proliferative effect on mucin - producing
conjunctival goblet cells, and inhibitory effect on lacrimal cell apoptosis.